Based on the statistically unambiguous gene prioritization from multiple-gene-conditioned fine-mapping analyses, it is likely that NR5A2, SATB2, and PPP3CA are shared susceptibility genes for both IBD and SCZ. This evidence concerns the gene SATB2 and inflammatory bowel disease.